Welcome to LookChem.com Sign In|Join Free
  • or
1-(3-(tert-butyl)-1-(4-(tert-butyldimethylsilyloxy)phenyl)-1H-pyrazol-5-yl)-3-(4-((3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-8-yl)oxy)naphthalen-1-yl)urea is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1352798-75-4

Post Buying Request

1352798-75-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1352798-75-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1352798-75-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,2,7,9 and 8 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1352798-75:
(9*1)+(8*3)+(7*5)+(6*2)+(5*7)+(4*9)+(3*8)+(2*7)+(1*5)=194
194 % 10 = 4
So 1352798-75-4 is a valid CAS Registry Number.

1352798-75-4Relevant academic research and scientific papers

RESPIRATORY FORMULATIONS AND COMPOUNDS FOR USE THEREIN

-

Paragraph 0318; 0319, (2013/06/28)

The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I).

RESPIRATORY FORMULATIONS AND COMPOUNDS FOR USE THEREIN

-

Page/Page column 56, (2012/01/06)

The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1352798-75-4